Skip to content
grad
Clinical Trials Portal

Clinical Trials Portal

Bon Secours Richmond Health System

  • Home
  • FAQs
Posted on April 23, 2019April 23, 2019 by Melissa Eckert

NRG Oncology NRG-BR004

A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First Line HER2-Positive Metastatic Breast Cancer

Read more about this trial →

← Back to available clinical trials

Post navigation

Previous PostPrevious SWOG LUNG-MAP
Next PostNext Merck MK3475-756

Want to Know More?

Our Department participates in the National Cancer Institute Community Oncology Research  Program (NCORP). We are currently the top accruing site for treatment trials within our NCORP. We would not be able to hold this achievement without each of our patients and our hard work is a testament to them!

Check out these informational videos provided by the National Cancer Institute to learn more about Clinical Research.

APPOINTMENTS AVAILABLE

To inquire about participation in a clinical trial, please contact us by phone at (804) 893-8717 or by email at rvaoncologyresearch@bshsi.org

See our FAQs

logo

logo logo

Bon Secours International | Sisters of Bon Secours USA | Bon Secours Health System
This page is managed by the Bon Secours Richmond Health System in Richmond, VA.
© 2017 Bon Secours Health System, Inc.

  • Yelp
  • Facebook
  • Twitter
  • Instagram
  • Email
Proudly powered by WordPress